Subscribe Now
Rankings
Magazine
Newsletters
Podcasts
Video On Demand
Fortune Live Media
Fortune Connect
Fortune Education
Fortune Well
Fortune Crypto
Fortune Recommends
rankings
See All Rankings
Fortune 500
Global 500
40 Under 40
GREAT PLACE TO WORK LISTS
Best MBA Programs
Magazine
Newsletters
Podcasts
more
Video On Demand
Fortune Live Media
Fortune Connect
Fortune Education
Fortune Well
Fortune Crypto
Fortune Recommends
SEARCH
SIGN IN
Subscribe Now
Valeant Pharmaceuticals
4 pages
Health
Valeant under federal investigation for how it prices drugs
BY
Laura Lorenzetti
October 15, 2015
Health
Biotech stocks dive as lawmakers take aim at Valeant for drug price hikes
BY
Laura Lorenzetti
September 28, 2015
MPW
Valeant had the hots for ‘female Viagra,’ Sprout CEO says
BY
Jen Wieczner
August 20, 2015
Health
Valeant snaps up ‘Female Viagra’ maker Sprout for $1 billion
BY
Geoffrey Smith
August 20, 2015
Finance
The real reasons for the pharma merger boom
BY
Jen Wieczner
July 28, 2015
Finance
Teva in talks to buy Allergan’s generic drug business
BY
Reuters
July 26, 2015
Finance
Endo International makes competing bid for Salix Pharmaceuticals
BY
Reuters
March 11, 2015
Finance
Fat Pharma: Pfizer-Hospira and the top 10 overpriced drug deals ever
BY
Jen Wieczner
February 6, 2015
Finance
After Allergan loss, is Valeant dumpster diving?
BY
Jen Wieczner
January 31, 2015
Finance
Zoetis shares spike on reported Ackman stake purchase
BY
Tom Huddleston Jr.
November 11, 2014
Is Valeant the wrong partner for Bill Ackman’s bid for Allergan?
BY
Sanjay Sanghoee
October 30, 2014
Finance
SEC is reportedly probing the Valeant-Ackman bid for Botox-maker Allergan
BY
Tom Huddleston Jr.
August 14, 2014
Finance
Morgan Stanley caught playing both sides of Allergan-Valeant fight
BY
Tom Huddleston Jr.
June 16, 2014
Finance
Valeant injects more cash into bid for Botox-maker Allergan
BY
Tom Huddleston Jr.
May 30, 2014
Valeant ready to beef up bid for maker of Botox
BY
Laura Lorenzetti
May 13, 2014
Most Popular
Health
The rise and fall of the Liver King—a social media sensation who is now being sued by his followers for $25 million
January 31, 2023
BY
Catalina Goanta
and
The Conversation
Finance
Warren Buffett’s right-hand man Charlie Munger, who once called crypto ‘rat poison,’ says we should follow China’s lead...
February 2, 2023
BY
Will Daniel
Success
You need to detach and ‘psychologically recover’ from work, professors say. The solution: commuting
February 2, 2023
BY
Matthew Piszczek
,
Kristie McAlpine
, and others
46 - 60 of 60 results
Previous Page
1
2
3
4